• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚专业培训对晚期卵巢癌管理的影响。

The impact of subspecialty training on the management of advanced ovarian cancer.

作者信息

Eisenkop S M, Spirtos N M, Montag T W, Nalick R H, Wang H J

机构信息

Center for Gynecologic Oncology, Encino, California 91436.

出版信息

Gynecol Oncol. 1992 Nov;47(2):203-9. doi: 10.1016/0090-8258(92)90107-t.

DOI:10.1016/0090-8258(92)90107-t
PMID:1468698
Abstract

A retrospective study was conducted to determine the influence of subspecialty training in gynecologic oncology as well as several other covariates on the feasibility, operative mortality, and survival benefits of cytoreductive surgery for 263 patients with stages IIIC and IVA epithelial ovarian cancer. Covariates most predictive of an optimal (< or = 1 cm) cytoreductive outcome were the diameter of the largest metastases before cytoreduction (< or = 10 cm vs > 10 cm, P < 0.001) and the specialty training of the physicians present at surgery (gynecologic oncologists vs other, P < 0.001). Age influenced operative mortality most (< 60 vs > or = 60, P < 0.001). Covariates found to most significantly influence survival time include the specialty training of the physicians present at surgery (gynecologic oncologists vs other, P < 0.0001), cytoreductive outcome (complete vs optimal, P = 0.001, optimal vs suboptimal, P < 0.0001), grade of tumor (grade 1 vs grades 2 and 3, P = 0.01), and pelvic disease status (frozen pelvis vs mobile primary tumor, P = 0.03). We conclude that patients with advanced epithelial ovarian cancer should undergo aggressive cytoreductive surgery by gynecologic oncologists, with the objective to remove all macroscopic disease. Subsequent treatment with platinum-based chemotherapy offers the best chance for long-term survival or cure.

摘要

开展了一项回顾性研究,以确定妇科肿瘤亚专业培训以及其他几个协变量对263例IIIC期和IVA期上皮性卵巢癌患者进行肿瘤细胞减灭术的可行性、手术死亡率和生存获益的影响。最能预测最佳(≤1 cm)肿瘤细胞减灭结果的协变量是细胞减灭术前最大转移灶的直径(≤10 cm与>10 cm,P<0.001)以及手术时在场医生的专业培训(妇科肿瘤学家与其他医生,P<0.001)。年龄对手术死亡率影响最大(<60岁与≥60岁,P<0.001)。发现对生存时间影响最显著的协变量包括手术时在场医生的专业培训(妇科肿瘤学家与其他医生,P<0.0001)、肿瘤细胞减灭结果(完全切除与最佳切除,P=0.001,最佳切除与次优切除,P<0.0001)、肿瘤分级(1级与2级和3级,P=0.01)以及盆腔疾病状态(冰冻盆腔与可活动的原发肿瘤,P=0.03)。我们得出结论,晚期上皮性卵巢癌患者应由妇科肿瘤学家进行积极的肿瘤细胞减灭术,目标是切除所有肉眼可见的病灶。随后进行铂类化疗为长期生存或治愈提供了最佳机会。

相似文献

1
The impact of subspecialty training on the management of advanced ovarian cancer.亚专业培训对晚期卵巢癌管理的影响。
Gynecol Oncol. 1992 Nov;47(2):203-9. doi: 10.1016/0090-8258(92)90107-t.
2
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.完全细胞减灭术在晚期上皮性卵巢癌患者中是可行的且能使生存率最大化:一项前瞻性研究。
Gynecol Oncol. 1998 May;69(2):103-8. doi: 10.1006/gyno.1998.4955.
3
What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?治疗晚期上皮性卵巢癌的妇科肿瘤学家目前的手术目标、策略和技术能力是什么?
Gynecol Oncol. 2001 Sep;82(3):489-97. doi: 10.1006/gyno.2001.6312.
4
A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.一种使用计算机断层扫描预测晚期卵巢癌患者手术结果的模型。
Cancer. 2000 Oct 1;89(7):1532-40. doi: 10.1002/1097-0142(20001001)89:7<1532::aid-cncr17>3.0.co;2-a.
5
Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.二次肿瘤细胞减灭术对晚期上皮性卵巢癌患者生存的影响。
Eur J Surg Oncol. 2000 Dec;26(8):798-804. doi: 10.1053/ejso.2000.1007.
6
Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study.复发性卵巢癌的二次细胞减灭术:一项前瞻性研究。
Cancer. 1995 Nov 1;76(9):1606-14. doi: 10.1002/1097-0142(19951101)76:9<1606::aid-cncr2820760917>3.0.co;2-h.
7
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.由妇科肿瘤专科顾问医生进行手术可提高卵巢癌患者的生存率。
Cancer. 2006 Feb 1;106(3):589-98. doi: 10.1002/cncr.21616.
8
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.妇科肿瘤学家对卵巢癌患者生存率的影响。
Obstet Gynecol. 2007 Jun;109(6):1342-50. doi: 10.1097/01.AOG.0000265207.27755.28.
9
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.手术细胞减灭术对IV期上皮性卵巢癌生存的影响。
Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145.
10
Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.最佳细胞减灭术是伴有肝转移的IV期上皮性卵巢癌的独立预后指标。
Gynecol Oncol. 2000 Aug;78(2):171-5. doi: 10.1006/gyno.2000.5841.

引用本文的文献

1
Rationale and Methodologic Approach for Assessing Ovarian Cancer Treatment and Gynecologic Oncologist Involvement in the Midwest Region of the United States.评估美国中西部地区卵巢癌治疗和妇科肿瘤学家参与情况的理由和方法学方法。
J Registry Manag. 2023 Fall;50(3):85-91.
2
pelvic resection of ovarian cancer with rectosigmoid colectomy: a literature review.卵巢癌盆腔切除术联合直肠乙状结肠切除术:文献综述
Gland Surg. 2021 Mar;10(3):1195-1206. doi: 10.21037/gs-19-540.
3
Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data.
腹腔化疗应用后的生存和复发:卵巢癌医院登记数据的回顾性分析。
Cancer Med. 2020 Oct;9(20):7388-7397. doi: 10.1002/cam4.3340. Epub 2020 Aug 19.
4
Female Pelvic Medicine and Reconstructive Surgery-What Does Certification Mean?女性盆底医学与重建外科——认证意味着什么?
Curr Urol Rep. 2018 Mar 19;19(5):30. doi: 10.1007/s11934-018-0785-0.
5
Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.妇科肿瘤学家参与卵巢癌护理标准的接受情况及生存情况。
World J Obstet Gynecol. 2016;5(2):187-196. doi: 10.5317/wjog.v5.i2.187. Epub 2016 May 10.
6
Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.综述文章:晚期和复发性上皮性卵巢癌治疗与监测中的新技术
Converg Sci Phys Oncol. 2017;3. doi: 10.1088/2057-1739/aa5cf1. Epub 2017 Feb 23.
7
In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon.追求卵巢癌患者的最佳肿瘤细胞减灭术:手术及外科医生的作用
J Obstet Gynaecol India. 2009 May-Jun;59(3):209-216.
8
Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995-2008.1995 - 2008年美国65岁以上女性卵巢癌的治疗与生存趋势
Obstet Gynecol. 2016 Jan;127(1):81-89. doi: 10.1097/AOG.0000000000001196.
9
Risk of malignancy index is not sensitive in detecting non-epithelial ovarian cancer and borderline ovarian tumor.恶性风险指数在检测非上皮性卵巢癌和卵巢交界性肿瘤方面并不敏感。
J Turk Ger Gynecol Assoc. 2010 Mar 1;11(1):22-6. eCollection 2010.
10
A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV.一项荟萃分析:卵巢癌国际妇产科联盟(FIGO)分期 III 期和 IV 期中,新辅助化疗与直接手术的比较。
World J Surg Oncol. 2013 Oct 10;11:267. doi: 10.1186/1477-7819-11-267.